Turkish Version of the Glaucoma Quality of Life-15 Questionnaire

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

127 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-05-27

Study Completion Date

2020-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Glaucoma is a disease with irreversible loss of visual field and optic neuropathy and is the most important cause of irreversible vision loss after cataract in the world. Although clinical evaluations reveal the level of glaucoma quantitatively, it is necessary to evaluate the impact of this pathology on daily functions and quality of life with a holistic perspective and to provide appropriate advice to patients according to the information obtained. Glaucoma Quality of Life -15 Questionnaire (GQoL-15) was developed by Nelson et al. in 2003 to evaluate the quality of life of glaucoma patients. The aim of this study is to translate GQoL-15 into Turkish and evaluate its test-retest reliability for Turkish-speaking population.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

How Has Glaucoma Affected Your Quality of Life?

NCT01476644

Glaucoma Quality of Life

COMPLETED NA

Testing YAG Laser Iridotomy for Primary Angle-Closure Glaucoma

NCT07195370

Glaucoma Eye Angle Closure Glaucoma

ACTIVE_NOT_RECRUITING NA

Ultrastructural Changes of Trabeculectomy Specimens in Patients With Uveitic Secondary Glaucoma

NCT00917670

Uveitis Secondary Glaucoma

COMPLETED

Quality of Life in Children Glaucoma and Cataract

NCT02490267

Paediatrics With Cataracts Paediatrics With Glaucoma

COMPLETED

Spectral Domain Optical Coherence Tomography Analysis for Glaucoma

NCT01612416

GLAUCOMA 1, OPEN ANGLE, D (Disorder)

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Glaucoma Quality of Life

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Determining quality of life

Quality of Life

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of primary open angle glaucoma more than 6 months with visual field tests,
* Have the sufficient cognitive level to answer the scale questions.

Exclusion Criteria

* To have retinal or optic nerve pathologies that may cause loss of visual field or decrease in visual field except glaucoma,
* To undergo eye surgery in the last 3 months.

Minimum Eligible Age

20 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No